Lactobacillus acidophilus для Irritable Bowel Syndrome (IBS)

References

1. [1] Uday C Ghoshal et al.. J Gastroenterol Hepatol. 2026. Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable Bowel Syndrome: A Double-Blind Randomized … doi:10.1111/jgh.70137 PubMed
2. [2] Theodore Rokkas et al.. Eur J Gastroenterol Hepatol. 2026. Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable bowel syndrome: a systematic review … doi:10.1097/MEG.0000000000003062 PubMed
3. [3] Anne Fennessy et al.. World J Gastrointest Pharmacol Ther. 2025. Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation … doi:10.4292/wjgpt.v16.i2.101268 PubMed
4. [4] Marlynna Sarkawi et al.. Sci Rep. 2024. A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome. doi:10.1038/s41598-024-60029-2 PubMed
5. [5] Sadegh Sulaimany et al.. Sci Rep. 2024. Computational prediction of new therapeutic effects of probiotics. doi:10.1038/s41598-024-62796-4 PubMed
6. [6] Mattia Tinazzi et al.. Yale J Biol Med. 2024. Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro … doi:10.59249/JOMF5336 PubMed
7. [7] Anita Gąsiorowska et al.. J Clin Med. 2024. Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … doi:10.3390/jcm14010006 PubMed
8. [8] Young Hoon Chang et al.. J Neurogastroenterol Motil. 2024. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. doi:10.5056/jnm23036 PubMed
9. [9] Lena Capirchio et al.. Int J Mol Sci. 2024. A Synbiotic Combining Chitin-Glucan and Lactobacillus acidophilus NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an … doi:10.3390/ijms251910732 PubMed
10. [10] Peiwei Xie et al.. Nutrients. 2023. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. doi:10.3390/nu15173856 PubMed
11. [11] Arzu Hizay et al.. Anaerobe. 2023. Lactobacillus acidophilus regulates abnormal serotonin availability in experimental ulcerative colitis. doi:10.1016/j.anaerobe.2023.102710 PubMed
12. [12] Ludovic D Langlois et al.. Int J Mol Sci. 2023. Effects of Glutamine, Curcumin and Fish Bioactive Peptides Alone or in Combination on Intestinal Permeability in a Chronic-Restraint Stress Model. doi:10.3390/ijms24087220 PubMed
13. [13] Veronica Cocetta et al.. Minerva Pediatr (Torino). 2023. Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins. doi:10.23736/S2724-5276.23.07128-8 PubMed
14. [14] V N Drozdov et al.. Vopr Pitan. 2023. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … doi:10.33029/0042-8833-2023-92-4-92-103 PubMed
15. [15] Seung Yong Shin et al.. J Neurogastroenterol Motil. 2022. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: … doi:10.5056/jnm21202 PubMed
16. [16] Cecilia Ceccherini et al.. Nutrients. 2022. Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis. doi:10.3390/nu14132689 PubMed
17. [17] Jin Lee et al.. Gastroenterol Res Pract. 2022. Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study. doi:10.1155/2022/9872230 PubMed
18. [18] Luisa Marras et al.. Microorganisms. 2021. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. doi:10.3390/microorganisms9040836 PubMed
19. [19] N Md Mokhtar et al.. Acta Gastroenterol Belg. 2021. Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink. doi:10.51821/84.4.009 PubMed
20. [20] Christopher J Martoni et al.. Nutrients. 2020. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. doi:10.3390/nu12020363 PubMed
21. [21] Barbara Skrzydło-Radomańska et al.. Nutrients. 2020. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … doi:10.3390/nu12071999 PubMed
22. [22] Stéphane Sadrin et al.. Dig Liver Dis. 2020. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. doi:10.1016/j.dld.2019.12.009 PubMed
23. [23] Jean Michel Maixent et al.. Cell Mol Biol (Noisy-le-grand). 2020. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future … PubMed
24. [24] Konstantinos Leventogiannis et al.. Probiotics Antimicrob Proteins. 2019. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth. doi:10.1007/s12602-018-9401-3 PubMed
25. [25] Ki-Bae Hong et al.. BMC Complement Altern Med. 2019. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model. doi:10.1186/s12906-019-2610-9 PubMed
26. [26] Mary Scriven et al.. Diseases. 2018. Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling. doi:10.3390/diseases6030078 PubMed
27. [27] K Preston et al.. Benef Microbes. 2018. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. doi:10.3920/BM2017.0105 PubMed
28. [28] Ya-Nan Cao et al.. Saudi J Gastroenterol. 2018. Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells. doi:10.4103/sjg.SJG_333_17 PubMed
29. [29] S Sadrin et al.. Cell Mol Biol (Noisy-le-grand). 2017. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial. doi:10.14715/cmb/2017.63.9.21 PubMed
30. [30] Anna Lyra et al.. World J Gastroenterol. 2016. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. doi:10.3748/wjg.v22.i48.10631 PubMed
31. [31] Bojana Bogovič Matijašić et al.. J Dairy Sci. 2016. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of … doi:10.3168/jds.2015-10743 PubMed
32. [32] Hyuk Yoon et al.. J Clin Biochem Nutr. 2015. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a … doi:10.3164/jcbn.15-14 PubMed
33. [33] Jun Sik Yoon et al.. J Gastroenterol Hepatol. 2014. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. doi:10.1111/jgh.12322 PubMed
34. [34] János Fehér et al.. Orv Hetil. 2014. [Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind … doi:10.1556/OH.2014.29987 PubMed
35. [35] María Ortiz-Lucas et al.. Rev Esp Enferm Dig. 2013. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. doi:10.4321/s1130-01082013000100005 PubMed
36. [36] Luise Mølenberg Begtrup et al.. Scand J Gastroenterol. 2013. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. doi:10.3109/00365521.2013.825314 PubMed
37. [37] Marina L Ritchie et al.. PLoS One. 2012. A meta-analysis of probiotic efficacy for gastrointestinal diseases. doi:10.1371/journal.pone.0034938 PubMed
38. [38] Bong Ki Cha et al.. J Clin Gastroenterol. 2012. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, … doi:10.1097/MCG.0b013e31823712b1 PubMed
39. [39] Javier Diaz Ferrer et al.. Rev Gastroenterol Peru. 2012. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome]. PubMed
40. [40] Tamar Ringel-Kulka et al.. J Clin Gastroenterol. 2011. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional … doi:10.1097/MCG.0b013e31820ca4d6 PubMed
41. [41] A C Ford. Aliment Pharmacol Ther. 2010. Probiotics in irritable bowel syndrome: underachievers or underpowered? doi:10.1111/j.1365-2036.2009.04223.x PubMed
42. [42] L Ohman et al.. Neurogastroenterol Motil. 2009. B-cell activation in patients with irritable bowel syndrome (IBS). doi:10.1111/j.1365-2982.2009.01272.x PubMed
43. [43] Kyoung Sup Hong et al.. Gut Liver. 2009. Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. doi:10.5009/gnl.2009.3.2.101 PubMed
44. [44] Dong Hyun Sinn et al.. Dig Dis Sci. 2008. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. doi:10.1007/s10620-007-0196-4 PubMed
45. [45] Eamonn M M Quigley. Curr Opin Pharmacol. 2008. Probiotics in functional gastrointestinal disorders: what are the facts? doi:10.1016/j.coph.2008.08.007 PubMed
46. [46] Christel Rousseaux et al.. Nat Med. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. doi:10.1038/nm1521 PubMed
47. [47] M Astegiano et al.. Minerva Gastroenterol Dietol. 2006. Treatment of irritable bowel syndrome. A case control experience. PubMed
48. [48] Thomas J Borody et al.. J Clin Gastroenterol. 2004. Bacteriotherapy using fecal flora: toying with human motions. doi:10.1097/01.mcg.0000128988.13808.dc PubMed
49. [49] Alfredo Saggioro. J Clin Gastroenterol. 2004. Probiotics in the treatment of irritable bowel syndrome. doi:10.1097/01.mcg.0000129271.98814.e2 PubMed
50. [50] A D Newcomer et al.. Am J Clin Nutr. 1983. Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. doi:10.1093/ajcn/38.2.257 PubMed